Biometrics

Medical Writing

Clinical reporting expertise

Convert the complexity of your clinical trial information into clear, understandable documentation. Our medical writing services provide full support for Phase I–IV clinical trials and medical device study documentation.

In-depth industry expertise

 

Our global team of medical writers produces technical and scientific documentation for a wide range of studies for both the EMA and FDA. Our writers have experience in over 40 therapeutic areas and hundreds of indications, and are native or fluent English speakers, with additional bilingual writing capabilities.

Comprehensive support for all your documents:

  • Protocols
  • EMA and FDA Briefing Packages
  • Investigator Brochures
  • Clinical Study Reports (CSR)
  • Marketing Documentation
  • Posters and/or Abstracts
  • Customized reports based on client requests
  • Development of scientific publications

Why choose Alira Health?

Together, the CROS NT and Alira Health biometrics team has provided expert statistical guidance for over 500 projects. As our partner, you’ll benefit from:

  • In-depth expertise across the complete clinical trial process
  • Flexible, tailored service delivered by global multidisciplinary teams
  • Efficient, safe, and successful study leadership
  • Exceptional customer service and site relations
  • Frequent, transparent, and professional communication
  • Comprehensive statistical guidance for regulatory communication and submission, study-based data management, biostatistics, and statistical programming

Related News

Publications September 16, 2022
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Biometrics Clinical eCOA
Publications September 7, 2022
The Promise and Reality of Decentralized and Hybrid Clinical Trials in Europe Today
To understand the challenges related to hybrid and decentralized trials and ways to overcome them, we spoke with Dr. Hervé Solatges, Product Management, Evidence, and Innovation (DCT(...)
Clinical Decentralized Clinical Trials Hybrid Clinical Trials
Publications September 5, 2022
Taking In-Licensed Biologics to Market: Challenges, Complexities, and Ways to Overcome Them
Taking a biologic through drug development to market is highly complex and filled with challenges. To understand these challenges, their implications and how to overcome them, we spoke(...)
Biologics Clinical Drug Development
Events August 10, 2022
DPHARM
We are pleased to announce that we will be sponsoring and attending DPHARM, a unique event focused on the latest innovations that modernize clinical trials.
Clinical Decentralized Clinical Trials DPHARM Patient Centric
Publications August 2, 2022
GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
The last two years have brought forward tremendous advances in the development of prophylactic and therapeutic approaches for the treatment of SARS-CoV-2 infections.
Clinical CMC Vaccines
Multimedia May 19, 2022
Fireside Chat Replay: Latest Developments in Oncology Supportive Care
In this fireside chat, we sit down with two medical experts in oncology and discuss some of the fascinating developments that are happening in the oncology supportive care field.
Clinical
Events May 19, 2022
DIA 2022 Global Annual Meeting
We are pleased to announce that we will be joining DIA 2022 Global Annual Meeting as exhibitors and delegates.
Biometrics Clinical Life Sciences Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.